medigraphic.com
ISSN 1561-302X (Print)

2023, Number 1

<< Back Next >>

Rev cubana med 2023; 62 (1)

Characterization of Severe Uncontrolled Asthma in Adults Older Than 60 Years

Díaz LO, Reytor OY, Legra DA, Lago MR, Fernández ON

Language: Spanish
References: 32
Page: 1-12
PDF size: 369.95 Kb.


ABSTRACT

Introduction: Patients older than 60 years tend to have more severe, less controlled asthma and worse lung function than younger people.
Objective: To characterize patients older than 60 years with severe uncontrolled asthma.
Methods: A descriptive, prospective and cross-sectional observational study was carried out at Benéfico Jurídico Pneumological Hospital from January 2020 to January 2021.
Results: The age group 60-69 years (76.5%) predominated. Women also predominated (61.8%), as well as family history of asthma or allergy (64.7%), and long-standing asthma (85.3%). Asthma associated with obesity and poor control was 55.9%. The reversibility of the forced expiratory volume in the first second (FEV1) after the application of the bronchodilator was 26.5%. The adherence to treatment was 61.8%. The future risk of adverse results was low (58.8%), which is the main factor, the current poor control in 100%.
Conclusions: Severe uncontrolled asthma in people over 60 years of age is more frequent in women, patients usually have family history of asthma or allergy, there is long-term asthma. It was observed that obesity is associated with poor control, the decreased FEV1 reversibility with the application of the bronchodilator, poor adherence to treatment and poor current control as a future risk of the disease.


REFERENCES

  1. Kuprys-Lipinska I. Prevalence, risk factors and under diagnosis of asthma in the general population Age over 60 years. Postepy Dermatol Alergol. 2019;36(1):86-91. DOI: https://doi:10.5114/ada.2018.733301.

  2. Organización Mundial de la Salud (OMS). Asma. 2022 [acceso 11/05/2022]. Disponible en: https://www.who.int/respiratory/asthma/es/.2.

  3. Ocampo J, Gaviria R, Sánchez J. Prevalencia del asma en América Latina. Mirada crítica a partir del ISAAC y otros estudios. Rev Alerg Mex. 2017;64(2):188-97. DOI: https://doi:org/0000?0002?7428?24133.

  4. Ministerio de Salud Pública. Dirección Nacional de Estadísticas Anuario Estadístico de Salud. 2020 [acceso 20/12/2021]. Disponible en: http://www.bvscuba.sld.cu/anuario-estadistico-de-cuba/.4.

  5. Wang E. Characterization of severe asthma worldwide: data from the international severe asthma registry. Chest. 2020;157(7):90-804. DOI: https://doi.org/10.1016/j,chest.2019.10.053.5.

  6. Cisneros Serrano C. Guidelines for severe uncontrolled asthma. Arch Bronconeumol. 2015;51:235-46. DOI: https://doi.org/10.1016/j.arbres.2014.12.0076.

  7. Álvarez-Gutiérrez FJ. Documento de consenso de asma grave en adultos. Actualización 2020. Sociedad española de Cirugía Torácica y Neumología. Open Respir Arch. 2020;2(3):158-74. DOI: https://doi.org/10.1016/j.opresp.2020.03.0057.

  8. Global strategy for asthma management and prevention.Ginasthma. 2020 [acceso 20/12/2021]. Disponible en: http//.www.ginasthma.org.

  9. Pérez Pacareu MI. Estudio de algunos parámetros de inmunidad humoral en pacientes asmáticos de la tercera edad. MediSur. 2008 [acceso 20/12/2021];6(3):9-14. Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/548/567.9.

  10. Jackson DJ. Characteristic on of patients with severe asthma in the UK Severe Asthma Registry in the biologic era. Thorax. 2021;76:220-7. DOI: http://doi:10.1136/thoraxjnl-2020-21516810.

  11. Chowdhury NU. Sex and gender in asthma. Eur Respir Rev. 2021;30:210067. DOI: http://doi:10.1183/16000617.0067-202111.

  12. Bulkhi AA. Elevated testosterone is associated with decrease likely hood of current asthma regardless of sex. Allergy Clin Immunol Pract. 2020;8:3029-35. DOI: http://doi:10.1016/j.jaip.2020.05.02212.

  13. Smith AM. Asthma in theel dearly: risk factors and impaction physical function. Ann Allergy Asthma Immunol. 2012;108:305-10. DOI: http://doi:org/10.1016/j.anai.2012.02.02213.

  14. Milanese M. Along be half of the ELSA Study Group. Asthma control in elderly asthmatics. An Italian observation al study. Respiratory Medicine. 2014;108:1091-9. DOI: http://doi:org/10.1016/j.med.2014.05.01614.

  15. Liu QH. Differences in the clinical characteristics of early-and late-on set asthma in elderly patients. Biomed Res Int. 2020;29:400296. DOI: http://doi: 10.1155/2020/294029615.

  16. Csoma Z. Prevalence and characterization of severe asthma in Hungary. Scientific Reports. 2020;10:9274. DOI: http://doi.org/10.1038/s41598-020-66445-416.

  17. Taylor B. Body mass index and asthma severity in the National Asthma Survey. Thorax. 2008;63(1):14-20. DOI: http://dx.doi.org/10.1136/thx.2007.08278417.

  18. Tay T. Comorbid "treatable raids" in difficult asthma: current evidence and clinical evaluation. Allergy. 2018;73(7):1369-82. DOI: http://doi.org/10.1111/all.1337018.

  19. Forno E. Adiposity and asthma in a nationwide study of children and adults in the United States. Ann Am Thorax Soc. 2018;15:322-30. DOI: http://doi.org/10.1513/AnnalsATS.201709?723OC19.

  20. Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141:1169-79. DOI: http://doi.org/10.1016/j.jaci.2018.02.00420.

  21. Westerhof GA. Predictors of frequent exacerbations in (ex) smoking and never smoking adults with severe asthma. Respir Med. 2016;118:122-7. DOI: http://doi:10.1016/j.rmed.2016.08.00621.

  22. Stapleton M. Smoking and asthma. J Am Board Fam Med. 2011;118:122-7. DOI: http://doi.org/10.3122/jabfm.2011.03.10018022.

  23. Pite H, Pereira AM, Morais-Almeida M, Nunes C, Ramo J, Fonseca JA. Prevalence of asthma and it association with rinitis in the elderly. Respir Med. 2014;108(8):1117-26. DOI: http://doi:10.1016/j.rmed.2014.05.002.Epub201423.

  24. Fernández de Córdova-Aguirre JC. Factores de riesgo para mal control de asma en adultos. Rev Alerg Mex. 2019;66(1):65-75. DOI: http://doi: 10.29262/ram.v66i1.55724.

  25. Lin J. Prevalence and risk factors of asthma in mainland China: The CARE study. Respir Med. 2018;137:48-54. DOI: http://doi.org/10.1016/j.rmed.2018.02.01025.

  26. Harding SM. The prevalence of gastro esophageal flux in asthma without reflux symptoms. Am J Respir Crit Care Med. 2000;162:34-9. DOI: http://doi:10.164/ajrccm.162.1.990707226. .PMID:10903216.

  27. Broers C. Review article: gastro-oesophagealreflux disease in asthma and chronic obstructive pulmonary disease. Aliment Pharmacology Ther. 2021;47:176-91. DOI: http://doi:10.1111/apt.14416.Epub201727.

  28. Gallucci M. Use of symptoms scores, spirometry, and other pulmonary function testing for asthma monitoring .Front Pediatric. 2021;7:54. DOI: http://doi:10.3389/fped.2019.0005428.

  29. Van Bragt JJMH, Characteristics and treatment regimen across ERS SHARP severe asthma registries. Eur Respir. 2021;55. DOI: http://doi: 10.1183/13993003.01163-201929.

  30. D'Avila Melo SM. Bronchodilator test in extreme old age: Adverse effects of short-acting beta-2 adrenergic agonists with clinical repercussion and bronchodilator response. Rev Assoc Med Bras. 2019;65(11):1343-8. DOI: http://doi.org/10.1590/1806-9282.65.11.134330.

  31. Sato K. The prevalence, characteristics, and patient burden of severe asthma determined by using a Japan Health Care Claims Database. Clinical Therapeutics. 2019;41(11):2239-51. DOI: http://doi.org/10.1016/j.clinthera.2019.08.01531.

  32. Goeman DP. Optimal management of asthma in elderly patients. Strategists improve adherence tore commended inventions. Drug Aging. 2007;24(5):381-94. DOI: http://doi.org/10.2165/00002512?200724050?0000332.




2020     |     www.medigraphic.com